Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

EU Project Studies Innovative Ways Of Diagnosing and Treating Cancer

10.03.2005


A project to study new and innovative ways of diagnosing and treating cancer is underway thanks to a grant of 10.4 million euros from the ’Life sciences, genomics and biotechnology for health’ thematic area of the EU’s Sixth Framework Programme (FP6).



CANCERDEGRADOME brings together the expertise of 41 scientists from 13 countries who, looking mainly on four of the most prolific types of cancer (breast, prostate, colorectal and skin), will focus on the complement of genes that encode enzymes that are known as proteases.

“Proteases are a diverse and important group of enzymes whose job is to cut or degrade other proteins”, says project co-ordinator Dylan Edwards, from the University of East Anglia. “Proteases function at different stages of tumour development and progression. In this project we plan to investigate the biology of proteases and then design specific inhibitors to block them.”


“One of the major problems we face in treating cancer is that patients who have the same type of cancer and are at the same disease stage respond very differently to therapy. So ideally we should look to identify those who are most at risk from their disease and provide them with treatment while, at the same time, sparing those who are not at risk from undergoing costly, unpleasant and unnecessary interventions.”

During the four-year project the CANCERDEGRADOME partners will use their knowledge of the degradome to create new drugs and develop novel specific interventions based on detailed knowledge of the roles of target proteases in cancer. The project will also aim to improve tumour imaging, so that cancers can be localised, characterised and treated at the earliest possible stages of the disease.

“The fight against cancer is a priority issue for the EU”, says Claire Horton, FP6UK’s National Contact Point for ’Life sciences, genomics and biotechnology for health. “Especially as it is estimated that our increasingly ageing population will lead to an extra 250,000 cancer diagnoses every year in Europe by 2020. That is why the European Cancer Proteases Consortium aims to improve the diagnosis of cancer so that patients can be identified when the disease is in its earliest, most treatable stage.

“The current Framework Programme (FP6) runs until 2006 and organisations wanting free information on how to access some of the 19 billion euros available should log on to http://fp6uk.ost.gov.uk or call central telephone support on 0870 600 6080.”

Dave Sanders | alfa
Further information:
http://fp6uk.ost.gov.uk

More articles from Health and Medicine:

nachricht Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign

nachricht Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>